Characterization of ouabain-like immunoreactivity in human urine

Stefan Worgall, Joerg Hänze, Roswitha Wagner, Christian Peiser, Rudolf E. Lang, E. Sulyok, Wolfgang Rascher

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective: To characterize ouabain-like immunoreactivity in human urine. Methods: Sensitive radioimmunoassay for ouabain characterized by high-peformance liquid chromatography. Results: Serial dilution of urinary immunoreactive ouabain paralleled the standard curve, but not so plasma immunoreactive ouabain. Intravenous administration of 86 nmol (62.5 μg) ouabain caused a rapid rise in ouabain immunoreactivity in plasma of healthy volunteers with a maximum of 1.7 nmol/l 8 min after injection and returned to basal levels after 6 h. Ouabain immunoreactivity rose to 36 nmol/l in urine, suggesting that exogenously administered ouabain can be measured reliably in plasma and urine. Analytical reversed-phase high-performance liquid chromatography (isopropanol-propanol biphasic gradient; linear acetonitrile gradient) of sample extracts before assay demonstrated measurable amounts of ouabain-related material only in native urine, but not in plasma. When plasma and urine were spiked with ouabain standard or normal volunteers were injected with ouabain, the assay reliably measured ouabain. Conclusion: A substance closely related to ouabain can be detected in urine, but circulates, if at all, in small amounts in human plasma.

Original languageEnglish
Pages (from-to)623-628
Number of pages6
JournalJournal of Hypertension
Volume14
Issue number5
DOIs
Publication statusPublished - 1996

Fingerprint

Ouabain
Urine
Healthy Volunteers
1-Propanol
2-Propanol
Reverse-Phase Chromatography
Liquid Chromatography
Intravenous Administration
Radioimmunoassay
High Pressure Liquid Chromatography

Keywords

  • Essential hypertension
  • High-performance liquid chromatography
  • Ouabain
  • Radioimmunoassay
  • Sodium

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology

Cite this

Worgall, S., Hänze, J., Wagner, R., Peiser, C., Lang, R. E., Sulyok, E., & Rascher, W. (1996). Characterization of ouabain-like immunoreactivity in human urine. Journal of Hypertension, 14(5), 623-628. https://doi.org/10.1097/00004872-199605000-00012

Characterization of ouabain-like immunoreactivity in human urine. / Worgall, Stefan; Hänze, Joerg; Wagner, Roswitha; Peiser, Christian; Lang, Rudolf E.; Sulyok, E.; Rascher, Wolfgang.

In: Journal of Hypertension, Vol. 14, No. 5, 1996, p. 623-628.

Research output: Contribution to journalArticle

Worgall, S, Hänze, J, Wagner, R, Peiser, C, Lang, RE, Sulyok, E & Rascher, W 1996, 'Characterization of ouabain-like immunoreactivity in human urine', Journal of Hypertension, vol. 14, no. 5, pp. 623-628. https://doi.org/10.1097/00004872-199605000-00012
Worgall, Stefan ; Hänze, Joerg ; Wagner, Roswitha ; Peiser, Christian ; Lang, Rudolf E. ; Sulyok, E. ; Rascher, Wolfgang. / Characterization of ouabain-like immunoreactivity in human urine. In: Journal of Hypertension. 1996 ; Vol. 14, No. 5. pp. 623-628.
@article{f18f9fb63f5e4df9a6ef3fe20189e282,
title = "Characterization of ouabain-like immunoreactivity in human urine",
abstract = "Objective: To characterize ouabain-like immunoreactivity in human urine. Methods: Sensitive radioimmunoassay for ouabain characterized by high-peformance liquid chromatography. Results: Serial dilution of urinary immunoreactive ouabain paralleled the standard curve, but not so plasma immunoreactive ouabain. Intravenous administration of 86 nmol (62.5 μg) ouabain caused a rapid rise in ouabain immunoreactivity in plasma of healthy volunteers with a maximum of 1.7 nmol/l 8 min after injection and returned to basal levels after 6 h. Ouabain immunoreactivity rose to 36 nmol/l in urine, suggesting that exogenously administered ouabain can be measured reliably in plasma and urine. Analytical reversed-phase high-performance liquid chromatography (isopropanol-propanol biphasic gradient; linear acetonitrile gradient) of sample extracts before assay demonstrated measurable amounts of ouabain-related material only in native urine, but not in plasma. When plasma and urine were spiked with ouabain standard or normal volunteers were injected with ouabain, the assay reliably measured ouabain. Conclusion: A substance closely related to ouabain can be detected in urine, but circulates, if at all, in small amounts in human plasma.",
keywords = "Essential hypertension, High-performance liquid chromatography, Ouabain, Radioimmunoassay, Sodium",
author = "Stefan Worgall and Joerg H{\"a}nze and Roswitha Wagner and Christian Peiser and Lang, {Rudolf E.} and E. Sulyok and Wolfgang Rascher",
year = "1996",
doi = "10.1097/00004872-199605000-00012",
language = "English",
volume = "14",
pages = "623--628",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Characterization of ouabain-like immunoreactivity in human urine

AU - Worgall, Stefan

AU - Hänze, Joerg

AU - Wagner, Roswitha

AU - Peiser, Christian

AU - Lang, Rudolf E.

AU - Sulyok, E.

AU - Rascher, Wolfgang

PY - 1996

Y1 - 1996

N2 - Objective: To characterize ouabain-like immunoreactivity in human urine. Methods: Sensitive radioimmunoassay for ouabain characterized by high-peformance liquid chromatography. Results: Serial dilution of urinary immunoreactive ouabain paralleled the standard curve, but not so plasma immunoreactive ouabain. Intravenous administration of 86 nmol (62.5 μg) ouabain caused a rapid rise in ouabain immunoreactivity in plasma of healthy volunteers with a maximum of 1.7 nmol/l 8 min after injection and returned to basal levels after 6 h. Ouabain immunoreactivity rose to 36 nmol/l in urine, suggesting that exogenously administered ouabain can be measured reliably in plasma and urine. Analytical reversed-phase high-performance liquid chromatography (isopropanol-propanol biphasic gradient; linear acetonitrile gradient) of sample extracts before assay demonstrated measurable amounts of ouabain-related material only in native urine, but not in plasma. When plasma and urine were spiked with ouabain standard or normal volunteers were injected with ouabain, the assay reliably measured ouabain. Conclusion: A substance closely related to ouabain can be detected in urine, but circulates, if at all, in small amounts in human plasma.

AB - Objective: To characterize ouabain-like immunoreactivity in human urine. Methods: Sensitive radioimmunoassay for ouabain characterized by high-peformance liquid chromatography. Results: Serial dilution of urinary immunoreactive ouabain paralleled the standard curve, but not so plasma immunoreactive ouabain. Intravenous administration of 86 nmol (62.5 μg) ouabain caused a rapid rise in ouabain immunoreactivity in plasma of healthy volunteers with a maximum of 1.7 nmol/l 8 min after injection and returned to basal levels after 6 h. Ouabain immunoreactivity rose to 36 nmol/l in urine, suggesting that exogenously administered ouabain can be measured reliably in plasma and urine. Analytical reversed-phase high-performance liquid chromatography (isopropanol-propanol biphasic gradient; linear acetonitrile gradient) of sample extracts before assay demonstrated measurable amounts of ouabain-related material only in native urine, but not in plasma. When plasma and urine were spiked with ouabain standard or normal volunteers were injected with ouabain, the assay reliably measured ouabain. Conclusion: A substance closely related to ouabain can be detected in urine, but circulates, if at all, in small amounts in human plasma.

KW - Essential hypertension

KW - High-performance liquid chromatography

KW - Ouabain

KW - Radioimmunoassay

KW - Sodium

UR - http://www.scopus.com/inward/record.url?scp=0029982326&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029982326&partnerID=8YFLogxK

U2 - 10.1097/00004872-199605000-00012

DO - 10.1097/00004872-199605000-00012

M3 - Article

VL - 14

SP - 623

EP - 628

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 5

ER -